PEP/NEWS — Peptide intel. Daily.

Pre-order The Hard Truth + get $494 in FREE bonuses (course, early chapters & live masterclass). https://www.renamalikmd.com/hardtruth In this episode, Holly Randal offers an unfiltered look at the adult film industry, discussing how change

Use code THOMAS at http://puori.com/THOMAS to get 32% off your first Puori Grass-fed Whey Protein order when you start a subscription! This video does contain a paid partnership with a brand that helps to support this channel. It is becaus

Researchers found that loose RNA-DNA hybrids in the cytoplasm of senescent cells trigger the release of inflammatory signals. Targeting these structures may offer a new way to dial down the chronic inflammation that accelerates aging.

In Aging Cell, scientists showed that antioxidants can selectively remove senescent muscle cells by altering mTOR signaling — the pathway that controls how cells sense nutrients. The findings point toward targeted senolytic strategies that spare healthy tissue.

Muscle-targeted delivery of FGF21 via viral vector boosted median lifespan by 20% in male mice and improved multiple healthspan markers. FGF21 is a key regulator in the caloric restriction pathway — and this study suggests it can be activated late in life with meaningful effect.

Nature Aging profiled the molecular effects of senolytic treatment in aged mice. Clearing senescent cells reshaped immune function, reduced fibrosis, and shifted metabolic markers — giving researchers a clearer map of what senolytic therapy actually does at the systems level.

A Nature Aging analysis reframes epigenetic clocks as measures of cumulative epigenetic drift rather than simple age predictors. That distinction changes how researchers should interpret clock data — and what interventions might actually move the needle.

Peter Attia reviews the evidence for growth hormone in adult tissue repair. Despite a plausible mechanism, the data has not consistently delivered on the promise — a useful read for anyone tracking GH secretagogue research.

Longevity clinic software startup Reya.ai was accepted into NVIDIA's Inception program, gaining computing resources and business development support. The company is focused on AI-assisted clinical decision-making for longevity medicine.

AI image company Midjourney is exploring preventive health through consumer-friendly body scanning. The move is unexpected but reflects a broader trend of tech companies entering the longevity space with a consumer-first lens.

A new analysis examines how insurers are rethinking their models as longevity science separates healthspan from lifespan. Actuarial tables built on chronological age may no longer capture the full picture — and the industry is starting to notice.

A deep-dive reference piece covering the biological foundations of cancer — how tumors form and which cellular pathways they exploit. Part one of a three-part series that builds toward peptide-specific risk and strategy discussions.

The final part of Research Vials' cancer series tackles GH secretagogues directly — addressing risk signals, washout considerations, and the current state of the evidence. Essential reading for anyone using or researching peptides in the GH/IGF axis.

PLOS Biology researchers found that sleep deprivation increases levels of SV2A — a marker tied to synaptic density — in the living human brain. The finding supports the synaptic homeostasis theory of sleep and has implications for recovery peptide research targeting neural repair.

Aging Cell published findings showing humanin — a mitochondrial peptide — reduces amyloid-beta-induced damage in retinal cells through an AMPK-Beclin1 pathway. The study adds to a growing body of work on mitochondria-derived peptides as neuroprotective agents.